NCT06164730: A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- State
- Under way
- Phase
- Phase 1
- People
- 85 planned
- Started
- 30 Apr 2024
- Primary completion
- Oct 2026
- Arms
- Cohort 1: Single Ascending Dose Escalation, Cohort 2: Single Ascending Dose Escalation, Cohort 3: Single Ascending Dose Escalation, Cohort 4: Single Ascending Dose Escalation, Cohort 5: Single Ascending Dose Escalation, Cohort 6: Single Ascending Dose Escalation, Cohort 7: Single Ascending Dose Escalation, Cohort 8: Single Ascending Dose Escalation, Cohort 9: Single Fixed Dose, Cohort 10: Single Fixed Dose
- Results
- None posted
- 11 Dec 2023: Trial registered
- 30 Apr 2024: Trial started